Page last updated: 2024-08-23

tobramycin and cyclic gmp

tobramycin has been researched along with cyclic gmp in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
D'Argenio, DA; Hoffman, LR; Jones, RA; MacCoss, MJ; Miller, SI; Zhang, Z1
Chambers, JR; Cherny, KE; Sauer, K1
Braeckmans, K; Coenye, T; Kaever, V; Sass, A; Teirlinck, E; Van Nieuwerburgh, F; Wille, J1
Biavasco, F; Carotti, E; Cedraro, N; Citterio, B; La Teana, A; Mangiaterra, G; Vaiasicca, S1

Other Studies

4 other study(ies) available for tobramycin and cyclic gmp

ArticleYear
Aminoglycoside antibiotics induce bacterial biofilm formation.
    Nature, 2005, Aug-25, Volume: 436, Issue:7054

    Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Bacterial Proteins; Biofilms; Cyclic GMP; Drug Resistance, Bacterial; Escherichia coli; Genes, Bacterial; Genetic Complementation Test; Phenotype; Pseudomonas aeruginosa; Tobramycin

2005
Susceptibility of Pseudomonas aeruginosa Dispersed Cells to Antimicrobial Agents Is Dependent on the Dispersion Cue and Class of the Antimicrobial Agent Used.
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:12

    Topics: Anti-Bacterial Agents; Bacterial Adhesion; Biofilms; Colistin; Cyclic GMP; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation, Bacterial; Glutamic Acid; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin

2017
Does the mode of dispersion determine the properties of dispersed Pseudomonas aeruginosa biofilm cells?
    International journal of antimicrobial agents, 2020, Volume: 56, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Biofilms; Colistin; Cyclic GMP; Drug Resistance, Bacterial; Humans; Moths; Pseudomonas aeruginosa; Tobramycin

2020
Contribution of Drugs Interfering with Protein and Cell Wall Synthesis to the Persistence of
    International journal of molecular sciences, 2021, Feb-05, Volume: 22, Issue:4

    Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; Biofilms; Ceftazidime; Cell Wall; Ciprofloxacin; Cyclic GMP; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation, Bacterial; Green Fluorescent Proteins; In Vitro Techniques; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin; Transformation, Bacterial

2021